Inhibitory actions of diphenyleneiodonium on endothelium‐dependent vasodilatations in vitro and in vivo

British Journal of Pharmacology

Volumn 110, Issue 3, 1993, Pages 1232-1238

  Wang, Yong‐Xiang ^a   Poon, Christina I ^a   Poon, Ken S ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

A23187; acetylcholine (ACh); blood pressure; Diphenyleneiodonium (DPI); endothelium dependent relaxation; FAD; nitric oxide synthase inhibitor; sodium nitroprusside (SNP)

Indexed keywords

ACETYLCHOLINE; ARGININE; CALCIMYCIN; DIPHENYLIODONIUM SALT; FLAVINE ADENINE NUCLEOTIDE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; CONCENTRATION RESPONSE; DEPRESSOR RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; PRESSOR RESPONSE; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ACETYLCHOLINE; AMINO ACID OXIDOREDUCTASES; ANIMAL; ARGININE; BLOOD PRESSURE; CALCIMYCIN; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; FLAVIN-ADENINE DINUCLEOTIDE; KINETICS; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NADH, NADPH OXIDOREDUCTASES; NADP; NITRIC-OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; ONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VASODILATION;

EID: 0027131836     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1993.tb13947.x     Document Type: Article

References (41)

1. G‐methylarginine, an inhibitor of endothelium‐derived nitric oxide synthesis, is a potent pressor agent in the guinea‐pig: does nitric oxide regulate blood pressure in vivo?
2. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP‐dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites
3. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P‐450 reductase
4. G‐monomethyl‐L‐arginine in vivo, in vitro and in cultured endothelial cell. In The Biology of Nitric Oxide 1
5. The effect of the inhibitor diphenylene iodonium on the superoxide‐generating system of neutrophils
6. Studies on the electron‐transfer mechanism of the human neutrophil NADPH oxidase
7. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils
8. Purification of a distinctive form of endotoxin‐induced nitric oxide synthase from rat liver
9. Some aspects of the pharmacology of diphenyleiodonium, a bivalent iodine compound
10. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages
11. Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein
12. Purification of insoluble nitric oxide synthase from rat cerebellum
13. Mechanism of action of the hypoglycemic agent diphenyleneiodonium
14. Induction of nitric oxide synthase is a necessary precondition for expression of tumor necrosis factor‐independent tumoricidal activity by activated macrophages
15. Inhibition of tumor cell ribonucleotide reductase by macrophage‐derived nitric oxide
16. Inhibition of endothelium‐derived relaxing factor‐dependent circulatory control in intact rats
17. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme
18. Brain nitric oxide synthase is a biopterin‐ and flavin‐containing multi‐functional oxido‐reductase
19. 2+‐dependently converts L‐arginine into an activator of soluble guanylate cyclase
20. Nitric oxide takes centre‐stage with newly defined roles
21. Nitric oxide: physiology, pathophysiology and pharmacology
22. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase
23. G‐nitro‐L‐arginine (L‐NNA)
24. Specific labeling of a constituent polypeptide of bovine heart mitochondril reduced nicotinamide‐adenine dinucleotide‐ubiquinone reductase by the inhibitor diphenyleneiodonium
25. Role of endothelium‐derived nitric oxide in the regulation of blood pressure
26. Characterization of three inhibitors of endothelial nitric oxide synthesis in vitro and in vivo
27. Other oral hypoglycemic agents
28. Purification and characterization of the cytokine‐induced macrophage nitric oxide synthase: an FAD‐ and FMN‐containing flavoprotein
29. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs
30. Synthesis of nitrogen oxides from L‐arginine by macrophage cytosol: requirement for inducible and constitutive components
31. FAD and GSH participate in macrophage synthesis of nitric oxide
32. G‐monomethyl‐L‐arginine on the blood pressure of pithed normotensive and spontaneously hypertensive rats
33. G‐nitro‐L‐arginine in pentobarbital‐anesthetized rats
34. G‐nitro‐l‐arginine on autonomic nerve activity
35. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase
36. Halothane inhibits pressor effects of diphenyleneiodonium
37. G‐nitro‐arginine on endothelium‐dependent relaxation of rat aorta
38. G‐nitro‐arginine methyl ester (NAME)
39. G‐nitro‐arginine in conscious rats are antagonized by L‐ but not D‐arginine
40. Nitric oxide synthase is a cytochrome P‐450 type hemoprotein
41. Calmodulin‐independent nitric oxide synthase from rat polymorphonuclear neutrophils